ARCHIVES

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Funding Opportunities (8-page issue).

April 18, 2003

Wendy Will Case Found Invites Applications For Small Grants

April 5, 1991

NCI Resumes Clinical Education Grants

March 18, 1983

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999